Back to search

Switzerland· 66255001

Ovaleap 300 IU/0.5 ml, solution injectable

A follitropin alfa product containing follitropinum alfa, registered in Switzerland by Labatec Pharma SA and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC G03GA05

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedOvaleap 300 IU/0.5 ml, solution injec…ATCG03GA05REGISTER NO.66255001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Follitropin alfa is registered in 12 of 19 countries.

Countries holding a registration under ATC G03GA05 (follitropin alfa), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Follitropin alfa · ATC G03GA05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
follitropinum alfa
Manufacturer
Labatec Pharma SA
Country
Switzerland (CH)
ATC code
G03GA05
ATC class
Follitropin alfa
Defined daily dose
75 E, P
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680662550018
    1 Stk
    CHF 116.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Follitropin alfa in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All follitropin alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Bemfola, Gonal-F
  • Liechtenstein · Bemfola, Gonal-F
  • Norway · Bemfola, Gonal-F

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c99c07ad-eb7d-4c55-91de-0c98a6dc00db
GET /v1/drugs/c99c07ad-eb7d-4c55-91de-0c98a6dc00db?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "follitropinum alfa 300 UI",
  "valid_from": "2018-11-01",
  "limitations": "[{\"description\":\"<b>Austausch Referenzpräparat/Biosimilar</b><br>\\nFür die Behandlung mit OVALEAP ist keine neue Kostengutsprache nötig, wenn in derselben Indikation bereits eine Kostengutsprache für das Referenzpräparat oder ein anderes Biosimilar besteht. <br>\\n\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-04-01\"}]",
  "galenic_form": "Inj Lös 300 IE/0.5 ml Patrone m 10 Nadeln",
  "therapeutic_area": null,
  "sl_inclusion_date": "2018-11-01",
  "self_retention_pct": 10
}

See everything about follitropin alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.